Related Experiment Video

Updated: Jun 11, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Irrelevant B-type natriuretic peptide levels in patients with mechanical prostheses in the mitral position presenting

Kensaku Higashi1, Hideki Tanaka, Hiroto Shimokawahara

  • 1Second Department of Cardiology, Kagoshima Medical Center, National Hospital Organization, Kagoshima, Japan. kensaku_hi@yahoo.co.jp

Circulation Journal : Official Journal of the Japanese Circulation Society
|July 8, 2010
PubMed

Insights

Plasma B-type natriuretic peptide (BNP) levels may not accurately indicate congestive heart failure (CHF) severity in patients with mitral mechanical prostheses. These prostheses were found to be an independent predictor of lower BNP levels in CHF patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Medical Devices

Background:

  • Plasma B-type natriuretic peptide (BNP) is a key marker for congestive heart failure (CHF).
  • Interpreting BNP levels in CHF patients can be challenging due to individual variability.
  • The impact of mitral mechanical prostheses on BNP levels in CHF is not well understood.

Purpose of the Study:

  • To investigate the influence of mitral mechanical prostheses on plasma BNP levels in patients with congestive heart failure.

Main Methods:

  • 214 consecutive CHF patients were enrolled, divided into groups with (n=31) and without (n=183) mitral mechanical prostheses.
  • Plasma BNP levels were measured, alongside clinical examinations and echocardiography.
  • Multivariate analysis was used to identify predictors of BNP levels.

Main Results:

  • No significant difference in left ventricular ejection fraction was observed between the groups.
  • Patients with mitral mechanical prostheses had significantly lower plasma BNP levels compared to those without.
  • Mitral mechanical prosthesis presence was identified as an independent predictor of decreased BNP levels.

Conclusions:

  • Plasma BNP levels may not accurately reflect CHF severity in patients with mitral mechanical prostheses.
  • Clinical interpretation of BNP in CHF patients with these devices requires careful consideration.
Abstract

More Related Videos

Isolation of Atrial Myocytes from Adult Mice08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...